Skip to main content
Clinical Trials/NCT05203432
NCT05203432
Unknown
Not Applicable

The Effect and Safety of Red Light Intervention on Myopic Progression of Myopic Children: Randomized Clinical Trial

Shanghai Eye Disease Prevention and Treatment Center1 site in 1 country104 target enrollmentFebruary 10, 2022

Overview

Phase
Not Applicable
Intervention
Red Light Intervention
Conditions
Myopia
Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Enrollment
104
Locations
1
Primary Endpoint
Changes of axial length
Last Updated
3 years ago

Overview

Brief Summary

To explore the effectiveness of using repeated low-level red-light therapy to slow myopia progression.

Registry
clinicaltrials.gov
Start Date
February 10, 2022
End Date
June 30, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age at enrolment: 6-12 years;
  • At least one eye with spherical equivalent refractions (SERs): -1.00 to -5.00 diopters (D), and stigmatism of 1.50 D or less;
  • Anisometropia of 1.5 D or less;
  • The BCVA of distant vision is at least 0.8;
  • Myopia progressed more than 0.5D in the past year;
  • Have normal thinking and language communication skills, and be able to actively cooperate with the treatment as required;
  • Written informed consent of guardian and child.

Exclusion Criteria

  • Strabismus, amblyopia or other ocular abnormalities;
  • Other systemic abnormalities;
  • Prior treatment of myopia control in 6 months, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc in either eye;
  • Atropine allergy;
  • Other situations that not suitable for participating in the trial as judged by the researcher.

Arms & Interventions

Red Light Intervention

Repeated Low-Level Red-Light Therapy

Intervention: Red Light Intervention

Low concentration atropine

0.01% atropine

Intervention: Atropine

Outcomes

Primary Outcomes

Changes of axial length

Time Frame: at least 1 year

AL was measured as the distance from the anterior corneal surface to the retinal pigment epithelium (RPE) using IOLMaster

Secondary Outcomes

  • Change of choroidal thickness(at least 1 year)
  • Change of spherical equivalent(at least 1 year)
  • Change of uncorrected visual acuity(at least 1 year)

Study Sites (1)

Loading locations...

Similar Trials